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is the IF equation’s denominator, is primarily 
subject to the journal’s editorial decisions. A fre‑
quently used tactic is to increase the number of 
references, which the IF depends on.
When making attempts to boost the journal’s 
IF, it should be highlighted that significant alter‑
ations of citation numbers led to temporary ex‑
clusions of journals from the JCR. Almost all of 
the banned journals, which make up less than 
0.5% of the total number, are excluded because of 
the excessive rate of self‑citations, all more than 
50% to 60%. In 2012, a Polish journal, Medical 
Science Monitor, and 2 other journals, Cell Trans-
plantation and The Scientific World Journal, were re‑
moved from the JCR since they apparently worked 
together to cite each other and thus raise their 
IFs. There are no examples of journals that were 
removed from the JCR due to significant increas‑
es in IF based on reducing the number of the ar‑
ticles published.
Of key importance for a journal’s IF is Thomson 
Reuters’ decision as to which article should be cat‑
egorized as a citable item and which not. It may 
markedly increase or decrease the denominator 
and consequently affect the IF.4,5 An increase in 
the “citable” items entering the denominator can 
result in a rapid fall of the IF, for example, in 1997, 
the IF of The Lancet decreased from about 17 to 12, 
following the inclusion of (citable) research letters 
to the denominator.6 Opthof et al7 have report‑
ed that solely accepting the high‑quality manu‑
scripts with a “100% priority score” assigned by 
the reviewers could increase the IF by about 40%, 
with the simultaneous reduction of the journal’s 
content below 30%.
Our policy regarding the IF equation’s denom‑
inator is to keep the balance between these strat‑
egies aiming at a higher IF in order to ensure 
a wider platform for publishing clinical and ba‑
sic studies in internal medicine, predominant‑
ly conducted in Poland. A rising number of valu‑
able submissions despite a relatively low accep‑
tance rate of about 25% prompts this decision, 
We are pleased to announce that the 2015 impact 
factor (IF) for the Pol Arch Med Wewn is 2.054. 
We maintain a solid position as the most pres‑
tigious Polish journal that publishes papers in 
internal medicine and related disciplines, such 
as cardiology, gastroenterology, allergology, and 
others (TABLE 1).
Our 2015 IF is slightly lower than that pub‑
lished for 2014 (FIGURE 1). Kiesslich et al1 have re‑
ported recently that among all journals listed in 
the Journal Citation Report (JCR) (n = 11 858), 
55.1% featured an increase in IF between the years 
2013 and 2014, while the IF of 44.6% of the jour‑
nals decreased and as few as 0.25% had their IF 
unaltered. Thus, the Pol Arch Med Wewn is not 
the only journal that has a lower current IF. As 
always, the reasons behind this change are com‑
plex. So, what decides on the IF?
A journal’s IF, a basic measure of the quality 
of journals, published each year by Thomson Re‑
uters, is calculated by dividing all citations to this 
journal within the particular year by the number 
of citable articles encompassing “substantive ar‑
ticles and reviews” published in this journal dur‑
ing the previous 2 years. It should also be point‑
ed out that the exact IF published by Thomson 
Reuters cannot be easily calculated using public‑
ly available data, and the final value always dif‑
fers slightly from the estimates.
A large number of known factors lead to an in‑
crease in IF. They include the selection of top‑
ics covered by a given journal, article types, lan‑
guage of publication, not to mention the various 
types of citation misconduct and inflation of IF.2
The “top‑ten JIF manipulation” aims to boost 
citations, either by means of direct editorial in‑
fluence on reference lists or by applying tactical 
measures, for example, the focus on trendy or 
“sexy” topics, all leading to an increase in the nu‑
merator of the IF equation.3 Another approach 
is to minimize noncitable articles in order to re‑
duce the denominator.3 In contrast to the num‑
ber of citations, the number of articles, which 
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interact directly on specific topics with authors 
using the Letter to the Editor section.
In September 2014, the Pol Arch Med Wewn 
transitioned to the pay‑to‑publish journal model, 
not without my doubts and some concerns. This 
was a major change that resulted in a transient 
decline in the number of submissions. It remains 
to be observed within a few months whether this 
with an additional issue scheduled for 2017, which 
makes a total of 11 issues annually. The Pol Arch 
Med Wewn aims to provide scientists and physi‑
cians of all levels of experience, coming from both 
the academic and nonacademic settings, with 
a forum to exchange views and novel findings in 
internal medicine. This journal gives all readers 
the opportunity to present their own data and 
TABLE 1 Changes in the impact factors (IFs) of Polish biomedical journals published in 2014 and 
2015; an arrow up indicates an increase in IF and an arrow down—a decrease
Abbreviated journal title IF 2015 IF 2014
J Physiol Pharmacol ↑  2.804 2.386
Arch Immunol Ther Ex ↓  2.464 3.176
Pharmacol Rep ↑  2.251 1.928
Pol Arch Med Wewn ↓ 2.054 2.121
J App Genet ↑  1.929 1.477
Arch Med Sci ↓ 1.812 2.030
Hered Cancer Clin Pr ↑  1.550 1.472
J Contemp Brachyther ↑  1.413 1.284
Postep Derm Alergol ↑  1.342 0.845
Pol J Pathol ↑  1.240 1.128
Folia Neuropathol ↓ 1.233 1.568
Adv Med Sci-Poland ↑  1.211 1.105
Cardiol J ↑  1.130 1.062
Adv Clin Exp Med ↑  1.127 1.095
Endokrynol Pol ↑ 1.112 0.933
Ann Transpl ↓ 1.032 1.261
Transl Neurosci ↓ 1.012 1.319
Videosurgery Miniinv 0.920 –
Ann Agric Environ Med ↓ 0.895 1.126
Psychiatr Pol ↑  0.884 0.733
Kardiol Pol ↑  0.878 0.539
Postep Hig Med Dosw ↑  0.769 0.573
Neurol Neurochir Pol ↑  0.747 0.641
Ginekol Pol ↑  0.609 0.601
Folia Morphologica ↑  0.469 0.336
Postep Kardiol Inter ↑  0.358 0.148
Cent Eur J Med ↑  0.309 0.153
FIGURE 1 Impact 
factor of Pol Arch Med 
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officially thank all our contributors, we organized 
the 2nd Meeting of the Polish Archives of Internal 
Medicine at the ICE Congress Center in Kraków, 
Poland, on May 20, 2016. A photo story from 
the meeting is presented in Appendix 1 to the cur‑
rent issue. In addition, the major contributors to 
the 2015 IF among the authors who published 
their work in the Pol Arch Med Wewn have been 
listed in TABLES 2 and 3.
We are proud of having an average turnaround 
time to the first editorial decision with review 
comments of 20 days and to the final decision 
change will decrease the quality of the journal, 
leading to lower IF in the near future. Such phe‑
nomenon has been observed in several journals. 
Despite the fact that each accepted submission 
generates profit for the Publisher, the editori‑
al board and myself intend to avoid the danger 
of lowering standards and accepting almost ev‑
ery article.
Traditionally, I would like to thank you all, our 
authors, reviewers, and editorial board members, 
for your invaluable contribution to the journal’s 
success. In recognition of these efforts and to 
TABLE 2 The most cited original articles published in Pol Arch Med Wewn in 2013 and 2014 that most contributed to its 2015 impact factor (based 
on the Web of Science, July 2016)




1 Endothelial function assessment in atherosclerosis: comparison of brachial artery flow‑mediated 
vasodilation and peripheral arterial tonometry.
Wilk G, Osmenda G, Matusik P, et al. Pol Arch Med Wewn. 2013; 123: 443‑452.
19 10
2 Osteoprotegerin as a marker of cardiovascular risk in patients on peritoneal dialysis.
Janda K, Krzanowski M, Chowaniec E, et al. Pol Arch Med Wewn. 2013; 123: 149‑155.
15 3
3 Bioresorbable vascular scaffolds in patients with acute coronary syndromes: the POLAR ACS study.
Dudek D, Rzeszutko L, Zasada W, et al. Pol Arch Med Wewn. 2014; 124: 669‑677.
15 9
4 Advanced glycation end‑products and arterial stiffness in patients with diabetic nephropathy and 
patients with chronic kidney disease without diabetes.
Strozecki P, Kurowski R, Flisinski M, et al. Pol Arch Med Wewn. 2013; 123: 609‑616.
11 4
5 Noninvasive ventilation for hypercapnic exacerbation of chronic obstructive pulmonary disease: 
factors related to noninvasive ventilation failure.
Nicolini A, Ferrera L, Santo M, et al. Pol Arch Med Wewn. 2014; 124: 525-531.
10 6
6 Effect of postconditioning on infarction size, adverse left ventricular remodeling, and improvement 
in left ventricular systolic function in patients with first anterior ST‑segment elevation myocardial 
infarction.
Elzbieciak M, Wita K, Grabka M, et al. Pol Arch Med Wewn. 2013; 123: 268‑276.
8 4
7 Reduced intake of dietary antioxidants can impair antioxidant status in type 2 diabetes patients.
Zujko ME, Witkowska AM, Gorska M, et al. Pol Arch Med Wewn. 2014; 124: 599‑607.
6 6
8 Correlation between the activity of the autonomic nervous system and endothelial function in 
patients with acute coronary syndrome.
Cieslik‑Guerra UI, Fila M, Kaminski M, et al. Pol Arch Med Wewn. 2014; 124: 509‑515.
6 6
TABLE 3 The most cited reviews published in Pol Arch Med Wewn in 2013 and 2014 that most contributed to its 2015 impact factor (based on 
the Web of Science, July 2016)




1 2012 revision of the Atlanta Classification of acute pancreatitis.
Sarr M. Pol Arch Med Wewn. 2013; 123: 118-124.
20 7
2 Anticoagulation management in nonvalvular atrial fibrillation: current and future directions.
Kornej J, Potpara T, Lip GYH. Pol Arch Med Wewn 2013; 123: 623‑634.
13 7
3 Practical aspects of new oral anticoagulant use in atrial fibrillation.
Undas A, Pasierski T, Windyga J, et al. Pol Arch Med Wewn. 2014; 124: 124‑135.
18 9
4 Obstructive sleep apnea, atrial fibrillation, and erectile dysfunction: are they only coexisting 
conditions or a new clinical syndrome? The concept of the OSAFED syndrome.
Szymanski FM, Puchalski B, Filipiak KJ. Pol Arch Med Wewn. 2013; 123: 701‑707.
12 6
5 New advances in stem cell research: practical implications for regenerative medicine.
Ratajczak MZ, Jadczyk T, Pedziwiatr D, et al. Pol Arch Med Wewn. 2014; 124: 417‑426.
11 7
6 Prevention of ischemic stroke in clinical practice: a role of internists and general practitioners.
Niewada M, Czlonkowska A. Pol Arch Med Wewn. 2014; 124: 540‑548.
9 5
7 Genetic risk factors of atherothrombosis.
Montagnana M, Danese E, Lippi G. Pol Arch Med Wewn. 2015; 124: 474‑482.
8 6
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of 36 days in 2015. It has been possible large‑
ly thanks to our reviewers. The names of those 
who were the most active in 2015 and always 
worked to deadlines are given in TABLE 4. Appre‑
ciation and recognition should be expressed to 
all our reviewers for their valuable contribution. 
The names of all reviewers who submitted a re‑
view to our journal in 2015 are listed in Appen‑
dix 2 to the July–August issue.
It is truly exciting to recognize medical stu‑
dents who are already making notable contribu‑
tions to clinical research and have found time to 
do science despite the rigorous demands of pursu‑
ing their medical education. The July–August is‑
sue of our journal features the best 3 students’ pa‑
pers.8-10 A photo story from the award winning cer‑
emony is presented in Appendix 3 to the July–Au‑
gust issue. The story features also the winners of 
the best paper prize, awarded each year to the au‑
thors of the best original paper published in the Pol 
Arch Med Wewn in the previous year.
For all who have already submitted their work 
to the Pol Arch Med Wewn, keep up the good work 
in 2016! For new authors who are interested in 
publishing their work in our journal, we encour‑
age you to publish with us. Our goal is to recov‑
er or even surpass the previous higher level of 
IF in 2017.
It is challenging to choose the right journal for 
a particular article. Among a number of different 
things to consider, including the prestige, impact 
factor, or the quality of reviews, some other as‑
pects indicate that the Pol Arch Med Wewn could 
be a good choice, especially for Polish clinicians 
dealing with a broad spectrum of clinical issues 
from internal medicine.
TABLE 4 Most active reviewers in 2015
No. Reviewer name
1 Artur Dziewierz





7 Małgorzata M. Bała
8 Michał Tendera
9 Grzegorz Opolski
10 Piotr Lipiec
